Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

<< Previous

Bullboard Posts

Next >>

Post by BioTeckon Jun 06, 2022 1:51pm

235 Views

Post# 34734703

Imagine Pharma

Hey Spill, call up these guys and get started on another deal. Actually tell Evotec to do it if you ever want it done.

I don't know much about these cells yet but it appears they use patients own cells and replicate. This could eliminate the need for immunosuppressants.

https://www.labiotech.eu/trends-news/diabetes-insulin/

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario